Scotts Miracle-Gro Chairman James Hagedorn Has Filed 2,207 Insider Transactions Totaling $312 Million in Sales

James Hagedorn, chairman and controlling shareholder of Scotts Miracle-Gro (SMG), has filed 2,207 insider transactions since 2003, selling a cumulative $312 million in company stock. His most recent filing from January 30, 2026 reveals a 142,315-share stock award valued at approximately $9.1 million at $64.22 per share — the largest single award in his filing history.

The Numbers

Metric	Value
Career Sell Value	$312 million
Total Transactions	2,207
First Transaction	2003
Last Transaction	Jan 30, 2026
Shares Remaining	142,315
Career Buy Value	$7,903

Recent Activity

Date	Type	Shares	Price	Est. Value
Jan 30, 2026	Award	142,315	$64.22	$9.14M
Jan 30, 2026	Transfer	38	$51.93	$1,973
Dec 26, 2025	Award	1,563	$57.76	$90K
Nov 13, 2025	Tax	18,216	$58.40	$1.06M
Nov 13, 2025	Award	41,353	—	—
Oct 28, 2025	Award	1,618	$55.81	$90K

Hagedorn's recent filing pattern is almost entirely compensation-related: stock awards arriving monthly at $1,500–2,000 share blocks (roughly $90,000 each), with larger annual awards of 40,000–142,000 shares. The November 2025 tax withholding of 18,216 shares at $58.40 is standard for a large vesting event. Notably absent from recent filings are open-market sales — his last direct sells were in prior years when SMG traded at higher levels.

What It Means

The Hagedorn family has controlled Scotts Miracle-Gro since the 1990s through a dual-class share structure that gives the family voting control regardless of their economic stake. James Hagedorn's $312 million in career sales represents decades of systematic monetization, primarily during the cannabis-boom years of 2020-2021 when SMG's Hawthorne Gardening subsidiary drove the stock above $230. The stock has since collapsed to the $60 range, and Hagedorn's shift from active selling to accumulating awards suggests he views current prices as a floor rather than an exit opportunity. His nearly $8,000 in career purchases is negligible, but the absence of selling at these depressed levels tells its own story.

What to Watch

• Whether Hagedorn begins selling again if SMG recovers toward the $80-100 range, which would signal he views the turnaround as mature
• The Hawthorne Gardening restructuring and whether the cannabis market recovery lifts the stock from its post-bubble lows
• Future award sizes — the January 2026 grant of 142,315 shares was unusually large, potentially tied to a new long-term incentive plan